Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-22
DOI
10.1038/srep33808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
- (2016) Ulf Schulze-Topphoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoimmune thyroid disorders
- (2015) Alessandro Antonelli et al. AUTOIMMUNITY REVIEWS
- Multiple Sclerosis and T Lymphocytes: An Entangled Story
- (2015) Laurine Legroux et al. Journal of Neuroimmune Pharmacology
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters
- (2015) Errol L. G. Samuel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Harnessing nanoparticles for immune modulation
- (2015) Daniel R. Getts et al. TRENDS IN IMMUNOLOGY
- TCR-triggered extracellular superoxide production is not required for T-cell activation
- (2014) Aleksey V Belikov et al. Cell Communication and Signaling
- Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
- (2014) Shyny Koshy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Imaging macrophages with nanoparticles
- (2014) Ralph Weissleder et al. NATURE MATERIALS
- A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
- (2014) M. Harunur Rashid et al. Scientific Reports
- Dysregulation of Macrophage Activation Profiles by Engineered Nanoparticles
- (2013) Vamsi Kodali et al. ACS Nano
- Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes
- (2013) Mohammed Mahidur Rahman et al. AGING CELL
- The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis
- (2013) Lindsey E. Padgett et al. Annals of the New York Academy of Sciences
- Biologic therapy for autoimmune diseases: an update
- (2013) Ziv Rosman et al. BMC Medicine
- Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
- (2013) Alexander J. Gill et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
- (2013) Ralf A. Linker et al. Current Neurology and Neuroscience Reports
- Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
- (2013) Laura A. Sena et al. IMMUNITY
- A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
- (2013) M. Harunur Rashid et al. PLoS One
- Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4
- (2013) V. O. Millien et al. SCIENCE
- Noncovalent Assembly of Targeted Carbon Nanovectors Enables Synergistic Drug and Radiation Cancer Therapy in Vivo
- (2012) Daisuke Sano et al. ACS Nano
- Antioxidant Carbon Particles Improve Cerebrovascular Dysfunction Following Traumatic Brain Injury
- (2012) Brittany R. Bitner et al. ACS Nano
- Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes
- (2012) Lara Lacerda et al. BIOMATERIALS
- Design of Poly(ethylene Glycol)-Functionalized Hydrophilic Carbon Clusters for Targeted Therapy of Cerebrovascular Dysfunction in Mild Traumatic Brain Injury
- (2012) Daniela C. Marcano et al. JOURNAL OF NEUROTRAUMA
- Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
- (2012) Shih Chieh Chang et al. TOXICON
- Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
- (2011) Daniel Ontaneda et al. Annual Review of Medicine
- KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
- (2011) Xueyou Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified Paclitaxel
- (2010) Jacob M. Berlin et al. ACS Nano
- Radical changes in multiple sclerosis pathogenesis
- (2010) Jack van Horssen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Water-soluble fullerene (c60) inhibits the development of arthritis in the rat model of arthritis
- (2010) Kazuo Yudoh International Journal of Nanomedicine
- Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression
- (2010) M. M. Kaminski et al. JOURNAL OF IMMUNOLOGY
- Is nanotechnology too broad to practise?
- (2010) Rebekah A. Drezek et al. Nature Nanotechnology
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block
- (2008) Melanie P. Matheu et al. IMMUNITY
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Endotoxin Limits in Formulations for Preclinical Research
- (2007) Padma Malyala et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started